Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Candel Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/29/2023 |
4
| Gaeta Renee (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 14,240 options to buy
@ $1.22, valued at
$17.4k
|
|
| 06/29/2023 |
4
| Nguyen Diem (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 14,240 options to buy
@ $1.22, valued at
$17.4k
|
|
| 06/29/2023 |
4
| Manning Paul B (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 14,240 options to buy
@ $1.22, valued at
$17.4k
|
|
| 06/29/2023 |
4
| Martell Christopher (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 14,240 options to buy
@ $1.22, valued at
$17.4k
|
|
| 06/29/2023 |
4
| Benz Edward J. JR (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 14,240 options to buy
@ $1.22, valued at
$17.4k
|
|
| 06/29/2023 |
4
| PAPA JOSEPH C (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 14,240 options to buy
@ $1.22, valued at
$17.4k
|
|
| 06/29/2023 |
4
| Aguilar-Cordova Estuardo (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 14,240 options to buy
@ $1.22, valued at
$17.4k
|
|
| 06/29/2023 |
4
| Nabel Gary J. (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 14,240 options to buy
@ $1.22, valued at
$17.4k
|
|
| 06/09/2023 |
4
| Loggia Nicoletta (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 28,480 options to buy
@ $1.51, valued at
$43k
|
|
| 06/09/2023 |
3
| Loggia Nicoletta (Director) has filed a Form 3 on Candel Therapeutics, Inc. |
| 05/02/2023 |
4
| Tak Paul Peter (CEO) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 180,000 options to buy
@ $1.29, valued at
$232.2k
|
|
| 05/02/2023 |
4
| Tyagarajan Seshu (Chief Technology Officer) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 90,000 options to buy
@ $1.29, valued at
$116.1k
|
|
| 05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2023 |
4
| Amello Jason (CFO) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 90,000 options to buy
@ $1.29, valued at
$116.1k
|
|
| 12/12/2022 |
4
| Barone Francesca (Chief Scientific Officer) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Bought 1,238 shares
@ $1.61, valued at
$2k
|
|
| 12/12/2022 |
4
| PAPA JOSEPH C (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Bought 3,014 shares
@ $1.7, valued at
$5.1k
Bought 35,018 shares
@ $1.94, valued at
$67.9k
|
|
| 12/12/2022 |
4
| Martell Christopher (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Bought 3,050 shares
@ $1.68, valued at
$5.1k
Bought 23,950 shares
@ $1.92, valued at
$46k
|
|
| 12/12/2022 |
4
| Tak Paul Peter (CEO) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Bought 3,050 shares
@ $1.7, valued at
$5.2k
Bought 12,935 shares
@ $1.92, valued at
$24.8k
|
|
| 12/12/2022 |
4
| Tyagarajan Seshu (Chief Technology Officer) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Bought 3,000 shares
@ $1.69, valued at
$5.1k
Bought 10,358 shares
@ $1.93, valued at
$20k
|
|
| 12/12/2022 |
4
| Amello Jason (CFO) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Bought 3,100 shares
@ $1.69, valued at
$5.2k
Bought 2,468 shares
@ $1.93, valued at
$4.8k
|
|
| 11/30/2022 |
4
| Amello Jason (CFO) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 90,877 shares
@ $0 |
|
| 11/30/2022 |
4
| Tak Paul Peter (CEO) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 195,906 shares
@ $0 |
|
| 11/30/2022 |
4
| Barone Francesca (Chief Scientific Officer) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 90,877 shares
@ $0 |
|
| 11/30/2022 |
4
| Nichols William Garrett (Chief Medical Officer) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 58,479 shares
@ $0 |
|
| 11/30/2022 |
4
| Tyagarajan Seshu (See Remarks) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 73,684 shares
@ $0 |
|
| 10/17/2022 |
4
| Aguilar-Cordova Estuardo (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 14,240 options to buy
@ $2.81, valued at
$40k
|
|
| 10/17/2022 |
4
| Nguyen Diem (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 14,240 options to buy
@ $2.81, valued at
$40k
|
|
| 10/17/2022 |
4
| Martell Christopher (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 14,240 options to buy
@ $2.81, valued at
$40k
|
|
| 10/17/2022 |
4
| Benz Edward J. JR (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 14,240 options to buy
@ $2.81, valued at
$40k
|
|
| 10/17/2022 |
4
| Manning Paul B (Director) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 14,240 options to buy
@ $2.81, valued at
$40k
|
|
| 09/23/2022 |
4
| Amello Jason (CFO) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 230,000 options to buy
@ $3.21, valued at
$738.3k
|
|
| 09/23/2022 |
3
| Amello Jason (CFO) has filed a Form 3 on Candel Therapeutics, Inc. |
| 09/14/2022 |
4
| Nichols William Garrett (Chief Medical Officer) has filed a Form 4 on Candel Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $3.75, valued at
$750k
|
|
|
|
|